Prometheus Biosciences, Inc.

Prometheus Biosciences, Inc. - ROEverified

RXDX

Price:

$199.92

Market Cap:

$9.56B

Prometheus Biosciences, Inc. is a biopharmaceutical company primarily focused on discovering, developing, and commercializing innovative therapeutics and complementary diagnostic products, mainly targeting inflammatory bowel diseases (IBD). Its flagship therapeutic candidate, PRA023, is a humanized IgG1 monoclonal antibody currently undergoing Phase IIa clinical trials. This investigational treatment is being evaluated for its potential in addressing ulcerative colitis and Crohn's disease, both forms of IBD, as well as systemic sclerosis-associated interstitial lung disease. Beyond its lead asset, Prometheus maintains an active development pipeline featuring several other programs targeting ...[Read more]

Industry

Biotechnology

IPO Date

2021-03-12

Stock Exchange

NASDAQ

Ticker

RXDX

The ROE as of June 2026 (TTM) for Prometheus Biosciences, Inc. (RXDX) is -31.12%

According to Prometheus Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -31.12%. This represents a change of 179.57% compared to the average of -11.13% of the last 4 quarters.

Prometheus Biosciences, Inc. (RXDX) Historical ROE (quarterly & annually)

How has RXDX ROE performed in the past?

The mean historical ROE of Prometheus Biosciences, Inc. over the last ten years is -26.47%. The current -31.12% ROE has changed 17.54% with respect to the historical average. Over the past ten years (40 quarters), RXDX's ROE was at its highest in in the December 2020 quarter at 8.84%. The ROE was at its lowest in in the March 2017 quarter at -69.26%.

Quarterly (TTM)
Annual

Average

-26.47%

Median

-38.25%

Minimum

-109.36%

Maximum

82.48%

Prometheus Biosciences, Inc. (RXDX) ROE by Quarter and Year

Discovering the peaks and valleys of Prometheus Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 60.84%

Maximum Annual ROE = 82.48%

Minimum Annual Increase = -195.04%

Minimum Annual ROE = -109.36%

Quarterly (TTM)
Annual
YearROEChange
2022-20.97%-45.17%
2021-38.25%-195.04%
202040.24%-51.21%
201982.48%-175.43%
2016-109.36%60.84%
2015-67.99%-4.88%

Prometheus Biosciences, Inc. (RXDX) Average ROE

How has RXDX ROE performed in the past?

The current ROE of Prometheus Biosciences, Inc. (RXDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.32%

5-year avg

-9.17%

10-year avg

-26.47%

Prometheus Biosciences, Inc. (RXDX) ROE vs. Peers

How is RXDX’s ROE compared to its peers?

Prometheus Biosciences, Inc.’s ROE is greater than Blueprint Medicines Corporation (-15.44%), greater than ImmunoGen, Inc. (-92.61%), greater than Cerevel Therapeutics Holdings, Inc. (-72.44%), greater than Roivant Sciences Ltd. (-6.85%), less than Oak Street Health, Inc. (464.00%), less than Reata Pharmaceuticals, Inc. (47.21%), greater than Karuna Therapeutics, Inc. (-36.44%), greater than Walgreens Boots Alliance, Inc. (-42.37%), greater than Signify Health, Inc. (-14.90%), greater than IVERIC bio, Inc. (-39.26%),

Build a custom stock screener for Prometheus Biosciences, Inc. (RXDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prometheus Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Prometheus Biosciences, Inc. (RXDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Prometheus Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Prometheus Biosciences, Inc.'s ROE?

How is the ROE calculated for Prometheus Biosciences, Inc. (RXDX)?

What is the highest ROE for Prometheus Biosciences, Inc. (RXDX)?

What is the 3-year average ROE for Prometheus Biosciences, Inc. (RXDX)?

What is the 5-year average ROE for Prometheus Biosciences, Inc. (RXDX)?

How does the current ROE for Prometheus Biosciences, Inc. (RXDX) compare to its historical average?